Purpose of the study
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19).
The purpose of this study program is to evaluate the effectiveness and safety of the study drug in adults with confirmed Coronavirus infection (COVID-19/ SARS-COV-2) and in people who are at high risk of Coronavirus infection (COVID-19/ SARS-COV-2).
Who may participate in this study?
You may qualify for this research study if the following applies to you:
-
You are at least 18 years old
-
You have tested positive for/ you are infected with Coronavirus (COVID-19/ SARS-CoV-2)
-
You have COVID-19 symptoms, such as: fever, dry cough, shortness of breath, sore throat etc.
-
You are currently not hospitalized AND you have not been previously hospitalized due to COVID-19
Reimbursement
You may receive reimbursement for expenses related to study participation. Information will be provided by the study doctor.
- CAN EARN COMPENSATION$$$
- VISIT at COVID STUDY
